Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice. | Breast Cancer Res | 2023 | 37386484 | PubTator, text mining | PubMed |
| High Expression of MRE11A Is Associated with Shorter Survival and a Higher Risk of Death in CRC Patients. | Genes (Basel) | 2023 | 37372450 | PubTator, text mining | PubMed |
| Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice. | Cancers (Basel) | 2023 | 37370804 | PubTator, text mining | PubMed |
| Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses. | Sci Adv | 2023 | 37343108 | PubTator, text mining | PubMed |
| NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. | Front Oncol | 2023 | 37342194 | PubTator, text mining | PubMed |
| Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies. | Investig Clin Urol | 2023 | 37341001 | PubTator, text mining | PubMed |
| An acquired BMF with FANCL gene heterozygous mutation: Case report. | Medicine (Baltimore) | 2023 | 37327301 | PubTator, text mining | PubMed |
| Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial. | Cancer Med | 2023 | 37325934 | PubTator, text mining | PubMed |
| Identification of Genomic Alterations in Thai Patients With Colorectal Cancer Using Next-Generation Sequencing-Based Multigene Cancer Panel. | Cureus | 2023 | 37323311 | PubTator, text mining | PubMed |
| Effectiveness of a question formulation rubric with second-year medical students: a randomized controlled trial. | J Med Libr Assoc | 2023 | 37312805 | PubTator, text mining | PubMed |
| Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. | Int J Mol Sci | 2023 | 37298484 | PubTator, text mining | PubMed |
| Telomere biology: from disorders to hematological diseases. | Front Oncol | 2023 | 37274248 | PubTator, text mining | PubMed |
| Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types. | Sci Rep | 2023 | 37264024 | PubTator, text mining | PubMed |
| FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. | Sci Adv | 2023 | 37256941 | PubTator, text mining | PubMed |
| Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy. | Front Oncol | 2023 | 37251919 | PubTator, text mining | PubMed |
| Precision Medicine in Bladder Cancer: Present Challenges and Future Directions. | J Pers Med | 2023 | 37240925 | PubTator, text mining | PubMed |
| Natural Gallic Acid and Methyl Gallate Induces Apoptosis in Hela Cells through Regulation of Intrinsic and Extrinsic Protein Expression. | Int J Mol Sci | 2023 | 37239840 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. | Genes (Basel) | 2023 | 37239385 | PubTator, text mining | PubMed |
| Interaction of Fumonisin B1, N-Palmitoyl-Fumonisin B1, 5-O-Palmitoyl-Fumonisin B1, and Fumonisin B4 Mycotoxins with Human Serum Albumin and Their Toxic Impacts on Zebrafish Embryos. | Biomolecules | 2023 | 37238625 | PubTator, text mining | PubMed |
| A multi-scale map of protein assemblies in the DNA damage response. | Cell Syst | 2023 | 37220749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=12